NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.88% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.34% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.99% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.79% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.61% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.49% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.41% |
| NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 2.38% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.36% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.02% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 1.99% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.96% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.88% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.80% |
| GEN | Genmab A/S | Other | Other | 1.77% |